GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,401,000 | -36.2% | 284,891 | -70.0% | 0.08% | -34.5% |
| Q2 2022 | $30,388,000 | +36.5% | 951,111 | +47.9% | 0.12% | +50.6% |
| Q1 2022 | $22,270,000 | +89.8% | 642,904 | +60.4% | 0.08% | +97.4% |
| Q4 2021 | $11,731,000 | +46.6% | 400,787 | +27.6% | 0.04% | +30.0% |
| Q3 2021 | $8,003,000 | -61.2% | 314,073 | -46.7% | 0.03% | -59.5% |
| Q2 2021 | $20,624,000 | -5.7% | 588,921 | +9.7% | 0.07% | -17.8% |
| Q1 2021 | $21,875,000 | +95.6% | 536,822 | +107.9% | 0.09% | +73.1% |
| Q4 2020 | $11,181,000 | -32.6% | 258,155 | -14.2% | 0.05% | -44.7% |
| Q3 2020 | $16,581,000 | +12.2% | 300,713 | +28.5% | 0.09% | -6.0% |
| Q2 2020 | $14,774,000 | – | 234,018 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |